Taken together, our findings suggest that the dysadherin/CA9 axis facilitates CRC cell adaptation to an acidic TME by promoting metabolic reprogramming, activating CAFs, and enabling immune evasion, thereby contributing to enhanced tumor malignancy. This evidence concerns the gene CA9 and colorectal carcinoma.